Pharma Blister Packaging provides robust, lightweight and cost-effective solutions for storing and transporting medicines and pharmaceutical products that require highly regulated temperatures and humidity levels. The demand for specialized packaging that prevents contamination and maintains drug integrity during distribution is driving the adoption of tamper evident, child-resistant packaging formats.
The global Pharma Blister Packaging Market is estimated to be valued at US$ 9.0 billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Growing demand for temperature sensitive packaging from pharmaceutical companies is one of the key trends shaping the pharma blister packaging market. Due to temperature fluctuations during transportation and storage, most pharmaceutical products need to be maintained within a specific temperature range. Blister packs integrated with active digital monitoring provide real-time alerts if temperature limits are exceeded, helping pharmaceutical companies prevent product wastage. Advanced packaging technologies that enable distribution of medicines requiring controlled temperature and humidity conditions will continue to gain traction. This is expected to propel the demand for pharma blister packaging with enhanced insulation and digital monitoring capabilities over the forecast period.
SWOT Analysis
1. Strength: Pharma blister packaging offers effective protection from damage, contamination and degradation during storage and transportation of drugs. It provides longer shelf life of pharmaceutical products.
2. Weakness: Blister packaging is a more expensive solution as compared to other packaging formats like bottles and containers. Change in design and tooling requires high investment which makes it less suitable for short production runs.
3. Opportunity: Growth of pharmaceutical industry worldwide and increasing demand for convenient packaging from consumers presents an opportunity for pharma blister packaging market. Rising demand for unit dose packaged drugs also supports the growth of this market.
4. Threats: Stringent regulations related to packaging materials used can affect market negatively. Substitute packaging formats like pouch packs, bottles are also posing a threat to the growth of pharma blister packaging market.
Key Takeaways
The global Pharma Blister Packaging market is expected to witness high growth. The global Pharma Blister Packaging Market is estimated to be valued at US$ 9.0 billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030.
Asia Pacific region is expected to be the fastest growing as well as dominating regional market for pharma blister packaging. Countries like China, India with huge population and developing pharmaceutical industry are key drivers of growth. Rapid economic development and increasing consumer spending on healthcare in Asia Pacific region makes it most lucrative market for pharma blister packaging.
Key players operating in the Pharma Blister Packaging market are Amcor, Constantia Flexibles, Klockner Pentaplast, Bemis, MeadWestvaco, Tekni-plex, Honeywell, CPH GROUP, Shanghai Haishun, Bilcare, IPS Ariflex, Zhong jin, Carcano Antonio, Aluberg, Goldstonepac. These key players are focusing on new product launches,expansion and collaborations to strengthen their market position.
